Vaginal Rejuvenation Market (2024 - 2030)

Vaginal Rejuvenation Market Summary

The global vaginal rejuvenation market size was estimated at USD 3.6 billion in 2023 and is projected to reach USD 14.34 billion by 2030, growing at a CAGR of 22.07% from 2024 to 2030. Changing women’s lifestyles and growing awareness of the associated therapy or surgery are expected to drive the vaginal rejuvenation market over the forecast period.

In addition, growing awareness of cosmetic procedures, especially female aesthetic genital surgery is anticipated to fuel the market in the future. The outbreak of COVID-19 led many aesthetic facilities to completely halt their services and permanently cancel appointments as they were considered non-essential and high contact in nature. Surgical aesthetic treatments like vaginal rejuvenation also witnessed a setback and the number of procedures declined due to the pandemic.

The increasing popularity of radiofrequency-based treatments is also driving the vaginal rejuvenation market. Radiofrequency-based devices, such as Viveve and Geneveve are gaining popularity owing to their non-invasive and safe single-session result nature, respectively. Viveve delivers volumetric radiofrequency of (90J/cm²) 3-5mm in vaginal tissue, which improves the blood circulation, whereas the 30-minute session by Geneveve treatment has improved the health and quality lives of thousands of women worldwide. Moreover, the treatment is proved effective for dryness due to childbirth and loss of vaginal elasticity.

Urinary incontinence, pelvic organ prolapse, overactive bladder syndrome, and fecal incontinence are some of the disorders prevalent in the U.S. Approximately 24% of women are suffering from one of the following conditions in the U.S.A. Precisely, 16% of women are suffering from urinary incontinence, 9% of women are affected by fecal incontinence, and 3% of women with pelvic organ prolapse. This number is anticipated to rise from 28.1 million (2010) to 43.8 million (2050). Hence, rising cases of uterine prolapse, birthing injuries, and urinary incontinence in women due to growing life expectancy are expected to drive the market.

Surging demand for energy-based treatments is also anticipated to fuel the vaginal rejuvenation market in the forthcoming years. Energy-based devices for the targeted surgery use either thermal or non-thermal energy for different layers of the vaginal tissue. This stimulates the regeneration of collagen, toughens the elastic fibers, helps neovascularization, and recovers vaginal lubrication.

Moreover, the growing success rate of radiofrequency and laser technologies in improving tissue properties, dermatology, and aesthetic medicine is affecting the growth of the vaginal rejuvenation market. The application of these technologies in vaginal rejuvenation has significantly expanded therapeutic indications in various biological tissue-related issues. Hence, devices incorporated with these technologies help women relish, reclaim, and improve their femininity to the fullest.

The pandemic affected the global aesthetic industry especially invasive cosmetic surgeries as the government in many countries mandated temporary shutdowns of aesthetic facilities. The third and fourth quarters of 2020 witnessed ease in lockdowns and many plastic surgeons and aesthetic centers started taking in appointments and consultations but with strict guidelines and limited patients per day. The number of labiaplasty procedures carried out globally decreased by 13% in 2020 as compared to 2019, according to the International Society of Aesthetic Plastic Surgery. However, the market is expected to recover from the effect of the pandemic, as the American Society of Plastic Surgeons stated, there is pent-up patient demand for invasive as well as non-invasive treatments post-pandemic.

Treatment Type Insights

The cosmetic vaginal rejuvenation segment held the largest market share of 66.0% in 2023 of the market. By treatment type, the vaginal rejuvenation market is divided into reconstructive vaginal rejuvenation and cosmetic vaginal rejuvenation. Reconstructive vaginal rejuvenation is further sub-segmented as perineoplasty and vaginoplasty. Cosmetic vaginal rejuvenation is also categorized as G-spot amplification, labioplasty, hymenoplasty, and hoodectomy. The cosmetic vaginal rejuvenation segment held a larger share of the market in 2023 owing to the increasing demand for surgeries, such as vaginoplasty, labia majoraplasty, monsplasty, clitoral hood reduction, and labiaplasty.

Amongst these, Labiaplasty is most commonly performed surgery due to an increasing number of issues related to the genital area. According to the American Society for Aesthetic Plastic Surgery (ASAPS), approximately 12, 756 surgeries were executed in 2018, with one surgery charging more than $53 million. ASAPS also predicts a 53% increase in the number of labiaplasty in the last 5 years.

The reconstructive vaginal rejuvenation segment is anticipated to grow at a significant rate over the forecast period owing to the growing number of patients reporting progression in prolapse, decreased vaginal sensation regarding vaginal wall laxity, and sexual dysfunction. Reconstructive vaginal rejuvenation is focused on repairing and correcting the structure of the vagina, especially after C-section delivery. This helps women to continue their lifestyle without complications or pain in urination, intercourse, and menstruation.

Type Insights

The surgical segment held the largest market share of 54.0% in 2023 of the market. By type, the market is divided into surgical and non-surgical. Non-surgical vaginal rejuvenation is further sub-segmented as laser, RF technologies, HIFU, and fillers. Labiaplasty accounts for the largest share of surgical type. Labiaplasty is a surgical procedure that involves reshaping or reducing the size of the labia minora (the inner folds of the vulva) or the labia majora (the outer folds). Women opt for labiaplasty for aesthetic reasons, to address discomfort caused by enlarged labia, or to improve the overall appearance of the genital area. The growing insurance coverage of labiaplasty in Western countries is expected to positively impact the market.

Nonsurgical vaginal rejuvenation, on the other hand, has a number of advantages, including being a less invasive choice for women looking to improve their personal wellbeing. One significant advantage is the lack of downtime, which allows people to resume normal activities immediately following the treatment. Nonsurgical rejuvenation therapies, including as laser therapy or radiofrequency treatments, are faster, more efficient, and less painful than surgical alternatives. Because of the aforementioned benefits, the segment is expected to grow rapidly.

Application Insights

The aging and childbirth segment held the largest market share of 43.9% in 2023 of the market. By application, the market is divided into incontinence, aging and childbirth, aesthetic purposes, and others. Physical changes in the female genitalia occur as a result of ageing and childbirth. Stretching of the vaginal tissues occurs during pregnancy and childbirth, and hormonal changes linked with ageing can contribute to concerns such as decreased elasticity, dryness, and changes in tissue tone. The rising trend of combining vaginal birth with vaginal tightening operations is projected to fuel market expansion. According to a PMC PubMed publication published in January 2020, vaginal birth with vaginal tightening surgery was determined to be a safe and successful approach.

The vaginal rejuvenation procedure also involves reshaping or reducing the size of the labia (the folds of skin surrounding the vulva) for aesthetic concerns. Moreover, women seek labiaplasty for cosmetic reasons, such as to address concerns about the appearance of enlarged or asymmetrical labia. Surgeons have practiced surgical labiaplasty for decades, establishing the procedure as a safe & effective outpatient procedure. The growing concern towards appearance is likely to drive the aesthetic segment.

Age Category Insights

The 30-40 segment accounted for the major share of 42.3% in 2023 of the market. By age category, the market is divided into below 20/20-30, 30-40, and 40 and above. Women between the ages of 30 and 40 are the most common clients for vaginal rejuvenation procedures worldwide. Pregnancy and childbirth loosen and weaken the interior tissue of the vagina in this age range. As the exterior vulva tissue expands, a syndrome known as Vaginal Relaxation Syndrome develops. Furthermore, when collagen production declines over time, the vaginal wall becomes dry and thin. Mild prolapse, urine incontinence, and perineal scarring are also symptoms of the illness.

However, the demand for vaginal rejuvenation is increasing in the 20-30 age range due to a variety of causes such as changing lifestyle and increased awareness of surgical and nonsurgical vaginal rejuvenation procedures. Furthermore, social media impact is playing an essential part in the market's growth in the 20-30 age group segment.

Regional Insights

The Asia Pacific market dominated the market with a revenue share of 28.9% in 2023 and is anticipated to grow at the highest CAGR of 23.11% during the forecast period. Rising awareness about vaginal rejuvenation in Japan, China, South Korea, India, & other south-east nations and low cost of surgeries are some of the key factors driving market growth. Moreover, the increasing adoption of noninvasive gynecological procedures is expected to improve the demand for vaginal rejuvenation.

North America registered a significant share of the market in 2023 owing to the increasing number of vaginal procedures and the high disposable income of consumers. The demand for labiaplasty surgery grew more than 24% in 2019. Moreover, the surgery offered 90% satisfaction among its patients. Owing to this factor, vaginal rejuvenation surgery is anticipated to be one of the common trends in 2023.

Key Companies & Market Share Insights

The players in the global market include Candela Corporation, Alma Lasers, Lutronic, Fotona, Viveve, BTL Group of Companies, VenusConcept, and Hironic. These players are adopting growth strategies, such as mergers and acquisitions, new product launches, development in the existing strategies, expansion of product portfolio, and more.

vConfidence is one of the leading players in the industry that offers modernized RF and laser technologies to cure women’s vaginal health. They have launched devices, such as Intima, FemiLift, Viveve Geneveve, and FemTouch.

When combined with other treatment protocols, these devices offer consistent and non-invasive results. In a single session of 5-minute treatment, the patients can resume their daily activities immediately. The treatment helps tighten the vaginal tunnel, improve menopausal dryness, balance pH, and improve thinning vaginal walls. The use of energy-based techniques, such as minimally ablative fractional laser and radiofrequency, for the treatment of vaginal laxity, orgasmic dysfunction, and stress incontinence is gaining traction.

Vaginal Rejuvenation Market